Trinity Biotech launches Legionella urine test
This article was originally published in Clinica
Executive Summary
Trinity Biotech has launched its rapid Legionella urinary antigen (LUA) test in Europe, Asia Pacific and Latin America. The 15-minute test, which uses the firm's Uni-Gold platform technology, is a lateral flow test for the qualitative detection of Legionella pneumophilia in the urine of patients with symptoms of pnuemonia.